Treatment with GLP-1 receptor agonists did not increase the incidence of adverse gastrointestinal outcomes in patients with inflammatory bowel disease. Medscape Medical News Source link : https://www.medscape.com/viewarticle/are-glp-1s-safe-gi-health-inflammatory-bowel-disease-2025a1000mj9?src=rss Author : Publish...
Read more











